Loss of tolerance to glycoprotein 2 isoforms 1 and 4 is associated with Crohn ’s disease of the pouch

ConclusionsThe novel anti ‐GP21 and GP24 antibodies are associated with Crohn's disease of the pouch in ulcerative colitis patients after IPAA. Serological anti ‐GP2 antibodies could aid in diagnosis of Crohn's disease of the pouch.

Source: Alimentary Pharmacology and Therapeutics - November 8, 2018 Category: Drugs & Pharmacology Authors: Donelle Cummings, Michael Cruise, Rocio Lopez, Dirk Roggenbuck, Vipul Jairath, Yinghong Wang, Bo Shen, Florian Rieder Tags: ORIGINAL ARTICLE Source Type: research